Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Thirumalai Chemicals Ltd

TIRUMALCHM
NSE
197.10
0.42%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Thirumalai Chemicals Ltd

TIRUMALCHM
NSE
197.10
0.42%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
2,376Cr
Close
Close Price
197.10
Industry
Industry
Speciality Chemicals
PE
Price To Earnings
PS
Price To Sales
1.30
Revenue
Revenue
1,834Cr
Rev Gr TTM
Revenue Growth TTM
-10.65%
PAT Gr TTM
PAT Growth TTM
193.22%
Peer Comparison
How does TIRUMALCHM stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
TIRUMALCHM
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
431523542492527555525447523450445416
Growth YoY
Revenue Growth YoY%
-26.1-15.8-5.2-3.222.26.1-3.1-9.2-0.7-18.9-15.2-6.9
Expenses
ExpensesCr
432485527498523524502467508477449431
Operating Profit
Operating ProfitCr
-13815-643124-2015-27-4-15
OPM
OPM%
-0.27.22.9-1.20.75.54.5-4.52.8-5.9-0.8-3.6
Other Income
Other IncomeCr
1156443908284
Interest Expense
Interest ExpenseCr
7101012109101415182621
Depreciation
DepreciationCr
161616151714131618222323
PBT
PBTCr
-1317-4-29-19119-50-11-64-44-55
Tax
TaxCr
062-6264-83-4-10-9
PAT
PATCr
-1311-6-23-2055-42-14-60-33-47
Growth YoY
PAT Growth YoY%
-114.3-82.3-117.5-376.8-59.4-52.2181.5-82.931.3-1,278.0-782.6-10.8
NPM
NPM%
-3.02.0-1.1-4.7-3.90.90.9-9.4-2.7-13.3-7.5-11.2
EPS
EPS
-1.31.0-0.6-2.2-2.00.50.5-4.1-1.4-5.9-3.1-3.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
1,0729441,0281,3121,2611,0851,0861,9982,1322,0832,0501,834
Growth
Revenue Growth%
-11.98.927.6-3.9-14.00.184.06.7-2.3-1.6-10.5
Expenses
ExpensesCr
1,0358468711,0221,0551,0078651,5571,9462,0322,0011,865
Operating Profit
Operating ProfitCr
3898158290206782214411865149-31
OPM
OPM%
3.510.415.322.116.37.220.322.18.72.52.4-1.7
Other Income
Other IncomeCr
8547122171230192122
Interest Expense
Interest ExpenseCr
352317131217212031424981
Depreciation
DepreciationCr
182536313644505756636185
PBT
PBTCr
-75510925316938157375129-35-41-174
Tax
TaxCr
7233983551539944045-20
PAT
PATCr
-1432711701142311828190-39-46-154
Growth
PAT Growth%
334.3119.8141.2-33.4-79.6407.9139.0-68.1-143.2-18.9-234.0
NPM
NPM%
-1.33.46.913.09.02.110.814.14.2-1.9-2.3-8.4
EPS
EPS
-1.33.16.91.711.12.311.527.58.8-3.8-4.5-14.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
101010101010101010101012
Reserves
ReservesCr
1832083885636586287931,0751,1821,1361,1451,521
Current Liabilities
Current LiabilitiesCr
2872513271443283013015558661,029926938
Non Current Liabilities
Non Current LiabilitiesCr
6650611081452612392213031,1451,7251,874
Total Liabilities
Total LiabilitiesCr
5475207868251,1411,2001,3431,8622,3603,3203,8074,345
Current Assets
Current AssetsCr
2812273703384594995731,0311,0531,1349611,094
Non Current Assets
Non Current AssetsCr
2662944174876817017708311,3082,1862,8463,251
Total Assets
Total AssetsCr
5475207868251,1411,2001,3431,8622,3603,3203,8074,345

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1531261088123414022140254237-66
Investing Cash Flow
Investing Cash FlowCr
-20-32-44-54-220-38-157-139-359-831-542
Financing Cash Flow
Financing Cash FlowCr
-141-93-52-161646-38-70206643375
Net Cash Flow
Net Cash FlowCr
-8012102914825194-9949-233
Free Cash Flow
Free Cash FlowCr
131988522413822140255237-64
CFO To PAT
CFO To PAT%
-1,114.3390.9153.047.4206.0602.8187.6143.160.3-611.1142.9
CFO To EBITDA
CFO To EBITDA%
407.0128.568.627.9113.6178.9100.091.329.1464.6-135.0

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
831849061,7499103618752,7241,7602,3972,487
Price To Earnings
Price To Earnings
0.06.112.810.38.015.67.49.719.60.00.0
Price To Sales
Price To Sales
0.10.20.91.30.70.30.81.40.81.11.2
Price To Book
Price To Book
0.40.82.33.01.40.61.12.51.52.12.1
EV To EBITDA
EV To EBITDA
5.12.45.76.04.54.23.45.39.359.880.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.730.434.440.434.328.440.240.028.220.122.6
OPM
OPM%
3.510.415.322.116.37.220.322.18.72.52.4
NPM
NPM%
-1.33.46.913.09.02.110.814.14.2-1.9-2.3
ROCE
ROCE%
9.027.429.442.724.36.718.131.79.40.30.3
ROE
ROE%
-7.114.717.829.817.03.614.725.97.5-3.4-4.0
ROA
ROA%
-2.56.29.020.79.91.98.815.13.8-1.2-1.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Thirumalai Chemicals Limited (TCL), founded in 1944 as a chemical trading firm and incorporated as a manufacturer in 1973, is a leading Indian specialty and industrial chemical company with a growing global footprint. Headquartered in Mumbai, TCL has evolved into a vertically integrated, technologically advanced chemical manufacturer with operations across India, Southeast Asia, Europe, and an upcoming facility in the United States. The company serves over 650 global customers across more than 60 countries in key sectors including food, pharmaceuticals, paints, plastics, agrochemicals, and consumer goods. With a strong focus on innovation, sustainability, and strategic expansion, TCL is transitioning toward higher-margin, value-added products while reinforcing its leadership in core commodity chemicals. --- ### **Core Products & Business Segments** TCL produces a diversified portfolio of industrial and specialty chemicals: - **Phthalic Anhydride (PA):** World’s largest single-train PA plant (100 KTPA) in Dahej; total PA capacity of ~327,000 TPA (Ranipet: 199 KTPA, Dahej: 128 KTPA). Used in plasticizers, UPR resins, paints, dyes, and construction materials. - **Maleic Anhydride (MAn):** Produced in Ranipet (India) and Malaysia (50 KTPA). Serves automotive, aerospace, coatings, and composites. - **Food & Pharma-Grade Acids:** - **Fumaric Acid:** Sole producer in India; used in food, pharma, and industry. - **Malic Acid:** Only producer in India and Southeast Asia; key acidulant in food and beverages (supplies global clients like Perfetti, Symrise). - **Diethyl Phthalate (DEP):** High-solvency plasticizer used in fragrances, cosmetics, and insect repellents. - **Ethanol & o-Xylene:** Supporting derivatives and internal processes. The company produces over 8 chemical products and is recognized as one of the few Indian producers with global-grade certifications for food and pharma-grade Maleic Anhydride and related derivatives. --- ### **Global Manufacturing Footprint** #### **India** - **Ranipet, Tamil Nadu (Est. 1973):** Flagship facility producing Phthalic Anhydride, Fumaric Acid, Malic Acid, DEP, and ethanol. Home to the newly established **TCL Technology and Engineering** division for modular plant construction. - **Dahej, Gujarat (Est. 2021):** World-class, fully automated, IoT-enabled facility operated via subsidiary **TCL Intermediates Pvt. Ltd.**, producing 128 KTPA PA and 10 KTPA Fumaric Acid. Located near demand hubs (60–80% of Indian customers within 250 km) and raw material sources. Fully commissioned and stabilizing by H1 FY26. #### **Malaysia** - **Optimistic Organic Sdn Bhd (OOSB):** 50 KTPA Maleic Anhydride plant, established via acquisition in 2012. Strategic hub for ASEAN and Middle East markets. Facing margin pressures due to Chinese oversupply; management exploring strategic options, including divestment. #### **United States** - **TCL Specialties LLC (New Martinsville, West Virginia):** Fully integrated, modularly constructed plant under construction. Will produce: - **40,500+ TPA Maleic Anhydride** - **30,000 TPA Food Ingredients (Malic & Fumaric Acid)** - **Start-up Target:** October–December 2025 (FY26), with full commercial operations by CY2026. - **Key Advantages:** - Low-cost **n-butane feedstock** (25% cheaper than Asia due to proximity to Appalachian shale gas). - **Fully backward-integrated** with self-generated energy (80% heat reuse from MAn process). - Modular construction from India’s Ranipet SEZ reduced capital cost and enabled faster deployment. - Expected **payback <7 years**. - Over **53% of U.S. volume growth** expected in non-commodity/value-added chemicals. --- ### **Strategic Initiatives & Competitive Edge** #### **1. U.S. Market Entry – High-Growth Opportunity** - **Import-Dependent Markets:** 65–70% of U.S. demand for Malic and Fumaric Acid is currently imported. - Strategic location within **1,000 miles of 40% of North American MAn customers** and near port/transport infrastructure. - Positioned to replace Asian imports facing high logistics costs and tariff risks. - Only limited competition expected from existing U.S. MAn producer due to lack of backward integration. - High barriers to entry for new players due to capital intensity and feedstock dependency. #### **2. Modular “Build in India for USA” Strategy** - Entire plant constructed in **Special Economic Zone (SEZ)** in Ranipet, shipped and assembled in West Virginia. - Reflects successful execution of **“Make in India”** and de-risked project delivery. - Offers cost control, quality assurance, and faster commissioning. #### **3. Vertical Integration & Proprietary Technology** - **Backward integration** into feedstocks (o-xylene, butane) ensures cost competitiveness. - **In-house developed technologies** for MAn, Malic Acid, Fumaric Acid, and DEP. - Holds **global patents** for efficient Maleic Anhydride production and by-product recovery. - Recovers **Maleic Anhydride, Benzoic Acid, and Fumaric Acid** from waste streams—turning waste into revenue. #### **4. R&D & Innovation** - Dedicated **R&D center in Ranipet** with pilot plant, automation, and IoT integration. - 8-member team; R&D spend of ₹2.4 crore (FY23–24), increasing in FY24–25. - Focus on **sustainability, process efficiency, new formulations**, and **eco-friendly packaging**. - Two new specialty products in development for commercialization within 5 years. --- ### **Financials & Investment Update (FY25–26)** - **FY25 Revenue:** ₹2,050 Crore - **Market Share:** ~37% of domestic PA market; leading global PA and Fumaric Acid producer. - **Exports:** ~6% of turnover (previously ~12%), with deliberate shift toward North America due to margin pressures in Europe. - **Capital Expenditure:** - **U.S. Project:** ~$240 million (entirely funded through internal accruals and debt taken 2.5 years ago). - **Dahej Project:** ₹750 Crore; fully funded via internal cash flows. - **Debt Status:** Took on first debt for Dahej and U.S. projects but maintains conservative financial policy. - **No Debt at Peak:** Debt-free status briefly achieved 18 months ago. --- ### **Operations & Supply Chain** - **Global Presence:** 4 manufacturing plants, subsidiaries in Malaysia, Singapore, USA, Netherlands (TCL Global B.V.), and UK. - **TCL Global B.V. (Netherlands):** European distribution hub. Profits in FY23; enhances margins, compliance (REACH), and service delivery. - **Logistics Efficiency:** - Dahej reduces Scope 3 emissions and cuts delivery times for Western India. - Modular construction slashes project timelines and costs. - **Sustainability Commitments:** - Zero wastewater discharge; emission scrubbing. - Circular economy practices: by-product recovery and waste-to-value conversion. - CSR through **Thirumalai Charity Trust** (women’s empowerment, healthcare, education since 1983). --- ### **Management & Governance** - **Leadership Transition:** - **Mr. CG Sethuram:** Former CEO, now focused on strategic growth and new ventures. - **Mr. Sanjay Sinha:** Appointed CEO (2021) with extensive global business experience. - **Global Teams:** Building cross-cultural, international management teams; hiring locally in the U.S.; training Indian personnel for global roles. - **Operational Resilience:** Demonstrated agility during pandemic, Ukraine war, and supply chain disruptions via alternate sourcing and operational flexibility.